CD19/CD20 dual-targeted chimeric antigen receptor-engineered natural killer cells exhibit improved cytotoxicity against acute lymphoblastic leukemia. - Yang, Na; Zhang, Caili; Zhang, Yingchun; Fan, Yuting; Zhang, Jing; Lin, Xiaojin; Guo, Ting; Gu, Yangzuo; Wu, Jieheng; Gao, Jianmei; Zhao, Xing; He, Zhixu (Journal of Translational Medicine, 2024)